Medscape

When a Jehovah’s Witness With AML Refuses Blood Transfusions

The refusal of blood transfusions by Jehovah’s Witnesses poses a major challenge in treating acute myeloid leukaemia (AML), ...

True Diagnostics Awarded BARDA RRPV Project to Advance Rapid Biothreat Test

True Diagnostics, Inc. announced today that it has been awarded a Project Award through the Rapid Response Partnership Vehicle (RRPV) to advance the development of the VeriClear EbV MARV Rapid Antigen ...

Autolus Therapeutics Announces First Patient Dosed in Phase 1 Trial of Obecabtagene Autoleucel (Obe-Cel) in Patients with Progressive Multiple Sclerosis

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...
360Dx

Hologic, Thermo Fisher Scientific, CDC, Others Gain FDA Clearances in September

The US Food and Drug Administration granted 510(k) marketing clearances for various tests to aid the diagnosis and treatment of infectious diseases, among other products.

New blood test could catch colon cancer without a colonoscopy

Guardant Health is breaking barriers and hoping to get more people screened through the “Shield” test. In 2024, over 53,000 ...
The Malaysian Reserve

GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the ...

SYMPLIFY, a prospective observational study, is the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals who presented with symptoms to primar ...